Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AUC-controlled withdrawal of cyclosporine or MMF in stable renal transplant recipients
NL-OMON27195Active, not recruiting
- Sponsor
- Roche
- Start
- Jan 2003
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Randomised, open-label trial of cyclosporine and mycophenolate mofetil (3 arms), sponsored by Roche. Primary endpoints: Composite graft outcome and Graft and patient survival. Started Jan 2003; status: active, not recruiting.
02
Drugs
cyclosporinemycophenolate mofetil
Beyond the preview
Go deeper on NL-OMON27195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27195.